CRISPR 2.0 is causing quite the ruckus in the scientific community. Why? Imagine that you had written a note in permanent marker, but later decided you wanted to change a single word. Without the ability to erase, your options would be limited, and further changes might make the note illegible. New CRISPR technologies, or “base editors,” behave as molecular erasers. These molecular erasers enable you to very precisely … Continue reading CRISPR 2.0: Genome engineering made easy as A-B-C
The Church lab at Harvard University recently announced plans to create a hybrid mammoth and elephant. Using a technology called CRISPR, researchers in the Church lab have learned how to insert mammoth DNA into the cells of modern elephants. Theoretically, this could set the stage for developing an embryo with DNA from both a modern elephant and the woolly mammoth. The group would like to … Continue reading Could Woolly Mammoths Walk Again?
by Christopher Gerry figures by Mike MacArthur The last few years have seen an explosion in our capacity to study the human genetic code. In particular, a technology called CRISPR/Cas9 has been at the forefront of many of these advances, capturing the imagination of scientists and the attention of the general public. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a type of bacterial self-defense … Continue reading Is Genetic Surgery in My Future?: A conversation with Dr. John Doench about CRISPR and genome editing
The first clinical trial using the gene editing technique CRISPR was given the go-ahead by panel from the US National Institutes of Health (NIH). The trial is aimed at determining if the technique is safe for use on human subjects. As there is much we have yet to learn about genes and their expression, it is a valid concern that modifying DNA in humans could … Continue reading First Human Trial of Gene Editing Technique CRISPR Approved
Advances in gene editing technology have spurred considerable progress towards a treatment for Duchenne muscular dystrophy (DMD). Although the disease is rare – affecting roughly 1 in 5,000 male births – its consequences are devastating: patients are confined to wheelchairs at an early age and often succumb to heart or respiratory failure in their twenties or thirties. No treatments are currently available, but three separate … Continue reading Gene editing emerges as a new therapeutic strategy for Duchenne muscular dystrophy